Thorne Healthtech, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Thorne Healthtech, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2019 to Q2 2023.
  • Thorne Healthtech, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 30, 2023 was $155M, a 24.1% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $155M +$30.2M +24.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $149M +$21.1M +16.5% Mar 31, 2023 10-Q 2023-08-09
Q4 2022 $147M +$28.3M +23.9% Dec 31, 2022 10-Q 2023-08-09
Q3 2022 $132M +$18.3M +16.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $125M +$207M Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $128M +$209M Mar 31, 2022 10-Q 2023-08-09
Q4 2021 $118M +$205M Dec 31, 2021 10-Q 2023-08-09
Q3 2021 $114M +$199M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$81.7M +$31M +27.5% Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$81.6M Mar 31, 2021 10-Q 2022-08-10
Q4 2020 -$86.8M +$20.1M +18.8% Dec 31, 2020 10-K 2023-03-31
Q3 2020 -$85.3M Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$113M Jun 30, 2020 10-Q 2021-11-10
Q4 2019 -$107M Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.